News of relief for corona patients, DCGI approves emergency use of 2-DG drug prepared by DRDO

News of relief for corona patients, DCGI approves emergency use of 2-DG drug prepared by DRDO

Photo credit: PTI

New Delhi: Amid growing cases of coronavirus, there is news of a relief for corona patients in India. India’s Drug Controller General (DCGI) has urgently approved the use of another vaccine for the treatment of corona. The drug has been developed in collaboration with DRDO’s Institute of Nuclear Medicine Allied Sciences and Hyderabad Center for Cellular and Molecular Biology. This drug is named 2-deoxy-D-glucose (2-DG).

After successful clinical trials of the drug, DCGI approved the drug for the treatment of corona. Rapid recovery has been seen in patients on whom the drug has been tried. At the same time, the dependence of patients on oxygen has also decreased. The Defense Research and Development Organization (DRDO) said in a statement on Saturday. The DRDO said in a statement that it can be easily prepared as it is an analogue of generic molecules and glucose. Also, it can be made available in a larger size. Read more: Cavid-19 vaccine: Are you going to be vaccinated? What to eat before and after vaccination? Learn expert opinions!

Let me tell you that in India, after two vaccines, Kovichen and Kovishield, a third Russian vaccine has been approved for the treatment of Sputnik V corona. Which is being given these three vaccines in India. Thus, it will become the fourth corona drug to treat corona virus in India. Which has been approved by DCGI. Vaccination in India to accelerate after DCGI approves fourth vaccine for urgent use for corona treatment

Avatar

About soumitra Mondal

Hi dear friends, I hope you are all well. My name is Soumitra mondal and I am a blogger. Friends, in this website I have told you about the latest technology updates. This website is an informatics website only.

View all posts by soumitra Mondal →

Leave a Reply

Your email address will not be published. Required fields are marked *